|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CS00523 |
| 保存条件 | store at -80℃ |
| 用途 | 仅用于科研用途 |
| 应用范围 | |
| 抗原来源 | CHO cells |
| CAS编号 | 1849636-24-3 |
| 保质期 | 一年 |
| 抗体名 | Tibulizumab (替布利珠单抗 ) |
| 是否单克隆 | |
| 克隆性 | |
| 靶点 | IL17A/TNFSF13B/CD257[Homo sapiens] |
| 适应物种 | |
| 形态 | |
| 宿主 | |
| 标记物 | |
| 包装规格 | 1mg/ml |
| 纯度 | % |
| 亚型 | |
| 标识物 | |
| 浓度 | 95% |
| 免疫原 | |
| 是否进口 | 否 |
Tibulizumab is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
货号（Catalog No.）icon
CS00523
通用名INNicon
Tibulizumab
纯度(Purity)icon
>95%
浓度( Concentration)icon
1mg/ml
Formulationicon
PBS buffer pH7.5
Sourceicon
CHO cells
内毒素(Endotoxin level)icon
Please contact with the lab for this information.
产品描述(Description)icon
Tibulizumab is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
别名(Alternative names)icon
LY 3090106,LY-3090106,LY3090106
靶点;物种(Specificity target name;species)icon
IL17A/TNFSF13B/CD257[Homo sapiens]
种类(Species)icon
Humanized
受体鉴定(Receptor identification)icon
IgG4-kappa-[scFv]2
